#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Drug eruption Shprintzen-Goldberg syndrome Chemical burn Neuromyelitis optica spectrum disorder Eosinophilic oesophagitis Familial hypertriglyceridaemia Hydrocephalus Hereditary hypophosphataemic rickets Metastases to central nervous system Adrenogenital syndrome Round cell liposarcoma HER2 mutant non-small cell lung cancer Hyperadrenocorticism Hereditary haemorrhagic telangiectasia More trials…

    Learn about Rare Diseases

    Rosai-Dorfman syndrome – Life with Disease Langerhans’ cell histiocytosis Focal segmental glomerulosclerosis – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Retinitis pigmentosa – Life with Disease Phenylketonuria – Diagnostics Prolymphocytic leukaemia – Basic Information Rosai-Dorfman syndrome – Trials in Disease Pleomorphic leiomyosarcoma – Life with Disease Lymphangiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-24F-116 Dolutegravir 177Lu-Rhpsma-10.1 M-(18F)-Fluorobenzylguanidine Inupadenant Hydrochloride Apitegromab ACICLOVIR SODIUM Sparsentan Testosterone Dried Ferrous Sulfate Tirzepatide DUVELISIB Amphotericine B, Liposome Adapalene Dexamethasone Base Bms-986442 HYDROXYCHLOROQUINE Imipenem Anhydrate Tiratricol Zalunfiban More therapies…

    Learn about Your Condition

    Vulvar dysplasia Liver transplant Embolism venous Chondrocalcinosis Angiosarcoma recurrent Menopause Dry mouth Depression Myocardial infarction Heart disease congenital Cartilage injury Coma White matter lesion Clostridium difficile colitis Tendon disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    • ORG-129
    Austria Denmark Germany Italy Poland Spain

  • Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Paclitaxel Albumin-Bound
    • Quemliclustat
    Austria Belgium Czechia France Germany Italy +3

  • Study on the Effects of Povorcitinib for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Diseases:
    • Neurodermatitis
    Investigated Drugs:
    • 4-[3-(Cyanomethyl)-3-(3′,5′-Dimethyl-1H,1’H-[4,4′-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
    Austria Bulgaria France Germany Italy The Netherlands +1

  • Title: Study of Solrikitug compared to placebo for adults with Eosinophilic Esophagitis to evaluate its effectiveness and safety

    Not recruiting

    2 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Solrikitug
    Belgium Italy The Netherlands Poland Spain

  • Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Nivolumab
    Croatia Czechia Estonia France Germany Hungary +6

  • Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Everolimus
    • Exemestane
    Belgium Bulgaria Czechia Denmark Finland France +8

  • Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health

    Not recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Resmetirom
    Belgium France Germany Italy Spain

  • Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Bendamustine Hydrochloride
    • Cyclophosphamide
    France Germany Italy Spain

  • Study on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany Hungary Italy +3
Previous Page
1 … 40 41 42 43 44 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!